Literature DB >> 20544326

Managing beta-blockers in acute heart failure: when to start and when to stop?

Mehmet Birhan Yilmaz1, Said Laribi, Alexandre Mebazaa.   

Abstract

The role of beta-blockers in heart failure has been long debated. Data from chronic heart failure studies clearly indicate that beta-blockers save lives. However, data concerning use of beta-blockers in patients with acute heart failure are limited, and only recently have emerged to help guide therapy. In this review, we provide an overview of when to stop and when to start beta-blockers in patients with acute heart failure.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20544326     DOI： 10.1007/s11897-010-0014-8

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN： 1546-9530


  31 in total

1.  Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.

Authors:  Markku S Nieminen; Michael Böhm; Martin R Cowie; Helmut Drexler; Gerasimos S Filippatos; Guillaume Jondeau; Yonathan Hasin; José Lopez-Sendon; Alexandre Mebazaa; Marco Metra; Andrew Rhodes; Karl Swedberg; Silvia G Priori; Maria Angeles Alonso Garcia; Jean-Jacques Blanc; Andrzej Budaj; Martin R Cowie; Veronica Dean; Jaap Deckers; Enrique Fernandez Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Morais; Ali Oto; Otto A Smiseth; Maria Angeles Alonso Garcia; Kenneth Dickstein; Anibal Albuquerque; Pedro Conthe; Maria Crespo-Leiro; Roberto Ferrari; Ferenc Follath; Antonello Gavazzi; Uwe Janssens; Michel Komajda; João Morais; Rui Moreno; Mervyn Singer; Satish Singh; Michal Tendera; Kristian Thygesen
Journal:  Eur Heart J       Date:  2005-01-28       Impact factor: 29.983

2.  Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up.

Authors:  Parag Patel; Donna L White; Anita Deswal
Journal:  Am Heart J       Date:  2007-04       Impact factor: 4.749

3.  2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2009-04-14       Impact factor: 24.094

4.  Role of B-type natriuretic peptide and echocardiographic indices in predicting the development of acute heart failure following beta-blocker uptitration in chronic heart failure patients with left ventricular systolic dysfunction.

Authors:  Ahmed Ben Driss; Jean-Yves Tabet; Philippe Meurin; Hélène Weber; Nathalie Renaud; Anne Grosdemouge; Claude Bourmayan
Journal:  Int J Cardiol       Date:  2007-02-07       Impact factor: 4.164

5.  Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study.

Authors:  Henry Krum; Ellen B Roecker; Paul Mohacsi; Jean L Rouleau; Michal Tendera; Andrew J S Coats; Hugo A Katus; Michael B Fowler; Milton Packer
Journal:  JAMA       Date:  2003-02-12       Impact factor: 56.272

6.  Rapid carvedilol up-titration in hospitalized patients with left ventricular systolic dysfunction--data from the Carvedilol in Hospital: Up-titration Limits after Acute Patients Admission registry.

Authors:  Manuel Martínez-Sellés; Tomás Datino; Marta Alhama; Nelida Barrueco; Isabel Castillo; Francisco Fernández-Avilés
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2010-05       Impact factor: 2.160

7.  Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.

Authors:  S B Felix; V Stangl; A Kieback; W Doerffel; A Staudt; K D Wernecke; G Baumann; K Stangl
Journal:  J Cardiovasc Pharmacol       Date:  2001-11       Impact factor: 3.105

8.  Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.

Authors:  Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Journal:  J Am Coll Cardiol       Date:  2008-07-15       Impact factor: 24.094

9.  Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.

Authors:  Wendy A Gattis; Christopher M O'Connor; Dianne S Gallup; Vic Hasselblad; Mihai Gheorghiade
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

10.  Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.

Authors:  Alexandre Mebazaa; Markku S Nieminen; Gerasimos S Filippatos; John G Cleland; Jeffrey E Salon; Roopal Thakkar; Robert J Padley; Bidan Huang; Alain Cohen-Solal
Journal:  Eur J Heart Fail       Date:  2009-01-21       Impact factor: 15.534
View more
  1 in total

1.  Acute heart failure with accompanying chronic obstructive pulmonary disease: should we focus on beta blockers?

Authors:  M R Ege; U Guray; Y Guray; M B Yilmaz; O Yucel; A Zorlu; I Tandogan
Journal:  Herz       Date:  2012-06-16       Impact factor: 1.443
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.